| Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis |
|
Jin Su Kim, Su Cheol Park |
|
Department of Internal Medicine, Korea Cancer Center Hospital, Korean Institute of Radiological and Medical Sciences, Seoul, Korea |
Correspondence:
Su Cheol Park,
Email: hepapark@kcch.re.kr
|
|
|
| Abstract |
|
Transarterial chemoembolization (TACE) has been widely performed as a treatment for
unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC
is increasing due to improvement of survival. Sorafenib has been generally accepted as a
standard treatment in advanced HCC. However, many HCC patients with EHM are treated with
TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause
of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for
the patients with HCC and EHM will be discussed. |
| Key Words:
Hepatocellular carcinoma; Extrahepatic metastasis; Transarterial chemoembolization |
|
NULL |
PDF Links
Full text via DOI
Download Citation
CrossRef TDM
E-Mail
